SCHEMBL4070202

SCHEMBL4070202

CC(C)(C(=O)Nc1ccc(C(F)(F)F)cn1)S(=O)(=O)c1ccc(C(F)(F)F)nc1.CC(C)(C(=O)Nc1nc(-c2ccccc2)no1)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 12/20 0.47
CNR1 P21554 8/20 0.45
GAA P10253 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ABCC9 O60706 1/20 0.39
ABCC8 Q09428 1/20 0.39
KCNJ11 Q14654 1/20 0.39
KCNJ8 Q15842 1/20 0.39
CCR6 P51684 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
USP36 Q9P275 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1464719 0.83 CNR2 (0.56) CNR2CNR1ALDH1A1TSHR
SCHEMBL469403 0.81 CNR2 (0.69) CNR2CNR1GAANPC1RAB9A
SCHEMBL1464391 0.80 CNR2 (0.55) CNR2CNR1GAAABCC9ABCC8
SCHEMBL1464594 0.77 CNR2 (0.57) CNR2CNR1GAAABCC9ABCC8
SCHEMBL1463790 0.75 CNR2 (0.54) CNR2CNR1GAAABCC9ABCC8
SCHEMBL1464878 0.75 CNR2 (0.64) CNR2CNR1GAAABCC9ABCC8
SCHEMBL1464948 0.74 CNR2 (0.56) CNR2CNR1ABCC9ABCC8KCNJ11
SCHEMBL1466231 0.72 CNR2 (0.53) CNR2CNR1GAAL3MBTL1ABCC9
SCHEMBL1464362 0.72 CNR2 (0.57) CNR2CNR1GAAABCC9ABCC8
SCHEMBL1464005 0.72 CNR2 (0.57) CNR2CNR1GAAABCC9ABCC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP disclosed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO disclosed